Home

Swedish Orphan Biovitrum stock

SWEDISH ORPHAN BIOVITRUM AB (BIOVF) Stock Price, News

SOBI Stock Price Swedish Orphan Biovitrum AB Stock Quote

  1. Profile. Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers specialty treatments in the area of genetics and metabolism. The company was founded in 2001 and is headquartered in Solna, Sweden
  2. 61,3%. More Financials. Company. Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core.
  3. About the Swedish Orphan Biovitrum AB stock forecast. As of 2021 August 05, Thursday current price of BIOVF stock is 20.080$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Swedish Orphan Biovitrum AB stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given.
  4. How has Swedish Orphan Biovitrum's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SOBI is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 4% a week
  5. Swedish Orphan Biovitrum General Information Description. Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006
  6. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company's website
With EPS Growth And More, Swedish Orphan Biovitrum (STO

The Swedish stock price prediction module provides an analysis of price elasticity to changes in media outlook on Swedish Orphan over a specific investment horizon. Using Swedish Orphan hype-based prediction, you can estimate the value of Swedish Orphan Biovitrum from the perspective of Swedish Orphan response to recently generated media hype. Swedish Orphan Biovitrum AB (publ)'s stock was trading at $20.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BIOVF shares have decreased by 6.3% and is now trading at $18.75. View which stocks have been most impacted by COVID-19 Stockholm Stock Market & Finance report, prediction for the future: You'll find the Swedish Orphan Biovitrum AB (publ) share forecasts, stock quote and buy / sell signals below. According to present data Swedish Orphan Biovitrum AB (publ)'s SOBI shares and potentially its market environment have been in bearish cycle last 12 months (if exists) CORPORATE GOVERNANCE | AGM Annual General Meeting 2021 The Annual General Meeting in Swedish Orphan Biovitrum AB (Sobi™), was held on Tuesday, 4 May 2021. Find out more Investors | Reports Interim Report Q2 2021 Sobi's interim report for the second quarter is now available. Report Webcast Presentation Media |.. Complete Swedish Orphan Biovitrum AB stock information by Barron's. View real-time BIOVF stock price and news, along with industry-best analysis

SOBI: Swedish Orphan Biovitrum AB Stock Price Quote

Swedish Orphan Biovitrum AB SOBI Morningstar Rating Rating as of Aug 17, 2021. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Stock Type — Employees. A high-level overview of Swedish Orphan Biovitrum AB (publ) (BIOVF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools Examine the latest technical analysis for the Swedish Orphan Biovitrum AB Share Swedish Orphan Biovitrum AB (publ) (SOBI:STO) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates

On eToro, you can buy $SOBI.ST or other stocks and pay ZERO commission! Follow Swedish Orphan Biovitrum AB share price and get more information. Terms apply 7 Wall Street analysts have issued ratings and price targets for Swedish Orphan Biovitrum AB (publ) in the last 12 months. Their average twelve-month price target is $20.00, predicting that the stock has a possible downside of 0.12%

BIOVF Stock SWEDISH ORPHAN BIOVITRUM Stock Price Today

User rankings according to the performance of their sentiments for the Swedish Orphan Biovitrum AB stock The Income Statement (earnings report) for Swedish Orphan Biovitrum AB. Find the company's financial performance, revenue, and more Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment.

SOBI Stock Price and Chart — OMXSTO:SOBI — TradingVie

  1. View the latest SOBI stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Swedish Orphan Biovitrum AB (publ)
  2. Description: Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hemophilia, immunology, and hereditary conditions. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement development.
  3. Swedish Orphan Biovitrum AB, SOBI: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events.
  4. Swedish Orphan Biovitrum AB. SOBI. Morningstar Rating. Rating as of Jul 9, 2021. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends.
  5. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Swedish Orphan Biovitrum AB share forecasts, stock quote and buy / sell signals below. According to present data Swedish Orphan Biovitrum AB's BIOVF shares and potentially its market environment have been in bearish cycle last 12 months (if exists)

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers specialty treatments in the area of genetics and metabolism. The company was founded in 2001 and is headquartered in Solna, Sweden Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hemophilia, immunology, and hereditary conditions. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement development programs in 2006 Swedish Orphan Biovitrum AB Stock Forecast. Over the next 52 weeks, Swedish Orphan Biovitrum AB has on average historically fallen by 4 % based on the past 7 years of stock performance. Swedish Orphan Biovitrum AB has fallen lower in 1 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 View detailed financial information, real-time news, videos, quotes and analysis on Swedish Orphan Biovitrum AB (OTC:BIOVF). Explore commentary on Swedish Orphan Biovitrum AB and hear what the.

SWEDISH ORPHAN BIOVITRUM AB (PUBL) : SOBI Stock Price

Swedish Orphan Biovitrum AB (publ) Stock Price (Quote) OMX:SOBI 176.90 kr (0% ) Friday, 20th Aug 2021 Range Low Price High Price Comment; 30 days: 162.00 kr: 177.20 kr: Friday, 20th Aug 2021 SOBI.ST stock ended at 176.90 kr. During the day the stock fluctuated 0% from a day low at 176.90 kr to a day high of 176.90 kr. 90 days At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back. Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Add to watchlist. Stockholm - Stockholm Real-time price. Currency in SEK. 166.85-.75 (-0.45% Market capitalization of Swedish Orphan Biovitrum (SOBI.ST) Market cap: $5.97 Billion As of August 2021 Swedish Orphan Biovitrum has a market cap of $5.97 Billion.This makes Swedish Orphan Biovitrum the world's 2141th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's. Swedish Orphan Biovitrum AB Annual stock financials by MarketWatch. View the latest SOBI financial statements, income statements and financial ratios

Swedish Orphan Biovitrum AB (BIOVF) stock price prediction

  1. Swedish Orphan Biovitrum AB (BIOVF) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets
  2. View today's stock price, news and analysis for Swedish Orphan Biovitrum AB (0MTD). Barron's also provides information on historical stock ratings, target prices, company earnings, market.
  3. On Friday, Swedish Orphan Biovitrum AB (publ) (SOBI:STO) closed at 176.70, 39.02% above the 52 week low of 127.10 set on May 06, 2021
  4. SWEDISH ORPHAN BIOVITRUM AB E:SOBIS - Turquoise is the European Multilateral Trading Facility (MTF) majority owned by London Stock Exchange Group in partnership with the user community, providing members a single connection to trade securities from 19 European and emerging markets as well as US stocks, IOB Depositary Receipts, ETFs and European Rights Issue
  5. Icelandic Stock Exchange First Page Nordic Indices European Indices US Indices Back : QUOTES: GRAPH: TECHNICAL ANALYSIS: SWEDISH ORPHAN BIOVITRUM (STO) 28,55 (2,89%
  6. Swedish Orphan Biovitrum. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company's website

BIOVF Swedish Orphan Biovitrum AB Latest News. Get news for OTC companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and. Swedish Orphan Biovitrum AB: Sobi to present data at the ISTH 2021 within rare haematology diseases. 2021-07-07 08:00 · Cision. Swedish Orphan Biovitrum AB: Sobi presenterar resultat inom sällsynta hematologiska sjukdomar vid ISTH 2021. 2021-06-29 17:46 · Nyhetsbyrån Direkt Swedish Orphan Biovitrum shares are less expensive than other comparable stocks. They are good value and are safely financed, but show below average growth. We recommend evaluating whether the future of the company Swedish Orphan Biovitrum is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this.

Swedish Orphan Biovitrum (OM:SOBI) - Share price, News

  1. This page features our users' sentiments regarding the Swedish Orphan Biovitrum AB ADR stock. They are displayed on both charts of different time periods and in a detailed table. No data available. Comment Guidelines
  2. This page features the latest news about the Swedish Orphan Biovitrum share
  3. For Swedish Orphan Biovitrum Ab (publ), the figure is an impressive 20.9%. High Return on Capital Employed - the measure of a company growing efficiently and profitably. - A 5-year average ROCE of more than 12 percent is a pointer to strong efficiency. For Swedish Orphan Biovitrum Ab (publ), the figure is an eye-catching 15.3%

Swedish Orphan Biovitrum Company Profile: Stock

Swedish Orphan Biovitrum AB analyst ratings, historical stock prices, earnings estimates & actuals. SOBI.SE updated stock price target summary A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years Swedish Orphan Biovitrum AB stock rating and analysis - : a summary of key financial strength and profitability metrics The Swedish Orphan Biovitrum AB (publ) PE ratio based on its reported earnings over the past 12 months is 21.95.The shares are currently trading at SEK178.2.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors

Swedish Orphan Biovitrum AB Stock Operating Data : latest news, headlines and research articles Stockholm Stock Exchange > Pharmaceuticals & Biotechnology > Swedish Orphan Biovitrum AB. Swedish Orphan Biovitrum AB SOBI. Dividend Summary. There have not been any declared dividends recently. Add Swedish Orphan Biovitrum AB to receive free notifications when they declare their dividends

SOBI, Swedish Orphan Biovitrum, (SE0000872095) - Nasda

Get detailed information about the dividend date and dividend announcements for Swedish Orphan Biovitrum Swedish Orphan Biovitrum AB (publ) Stock Signals OMX:SOBI Latest Data & Signals Issued. Signal Type Signal Value Data; Score 2.657 47 days ( 11.67 % ) Last Price 176.90 kr 0.11 % StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial. Financial summary of SWEDISH ORPHAN BIOVITRUM AB with all the key numbers The current SOBI/N market cap is 122.425B. The company's EPS TTM is 21.67, dividend yield is 0.00%, and P/E is 16.06. Next SWEDISH ORPHAN BIOVITRUM AB earnings date is October 29, the estimation is 2.00

Find the latest SEC Filings data for Swedish Orphan Biovitrum AB (BIOVF) at Nasdaq.com At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back. Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Add to watchlist. Stockholm - Stockholm Real Time Price. Currency in SE Swedish Orphan Biovitrum, även kända under namnet Sobi, är ett internationellt läkemedelsbolag. Störst inriktning återfinns inom tillhandahållandet av innovativa behandlingar och service för patienter med sällsynta sjukdomar. Produkterna som bolaget utvecklar fokuserar på inflammatoriska- samt genetiska sjukdomar On July 21, Swedish Orphan Biovitrum AB will release figures for Q2. Analysts expect earnings per share of SEK 0.621. Track Swedish Orphan Biovitrum AB stock price in real-time on Markets Insider.

Swedish Orphan Biovitrum aktie handlas på börsen i Sverige, på listan Large Cap, och med tickern SOBI. Aktien har ett P/E-tal på 19.2 och P/S-tal på 3.7 baserat på vinsten och omsättningen för de senaste 12 månaderna. Swedish Orphan Biovitrum utdelning och direktavkastnin Tato stránka obsahuje aktuální výpis údajů firmy Swedish Orphan Biovitrum s.r.o. Údaje byly staženy 2. května 2021 z datové služby justice.cz dle IČO 28171276 a údaje ve výpise nebyly dle systému ARES do dnešního dne změněny.. Z důvodu ochrany osobních údajů nejsou na stránce data narození a úplné adresy fyzických osob

Sobi - Swedish Orphan Biovitrum AB (publ) | 24,299 followers on LinkedIn. At Sobi, we are transforming the lives of people affected by rare diseases. | Sobi is a specialised international. Biologische Reaktionsmodifikatoren Markt 2021, Trends, Branchenanalyse, Größe, Anteil, Wachstum und COVID-19-Pandemie bieten zukünftige Chancen 2028 | AbbVie, Swedish Orphan Biovitrum, Amge

- Swedish Orphan Biovitrum AB and Takeda Pharmaceutical Co. Ltd. . Marktdynamik des Hämophilie Therapeutics-Marktes: - Markttreiber: Steigende Anzahl von Initiativen zur Schaffung eines Bewusstseins über Hämophilie. - Market Trends: F & E neuer Strategien, um Therapeuticsâ zu Entwickel Swedish Orphan Biovitrum AB to Host Earnings Call. NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Swedish Orphan Biovitrum AB (STO:SOBI) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021 at 1:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www Swedish Orphan Biovit Ord stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. STOCKHOLM , April 22, 2020 /PRNewswire/ -- On 29 April, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2020. Financial analysts.. Current stock quote for Swedish Orphan Biovitrum AB ( BIOVF ) including financial statements, level 2 data, and the latest Drug Manufacturers - Major news, research, and investment community discussio

Swedish Orphan Biovitrum is in a rising trend chan This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title Australian finance news, stock quotes, currency information and blogs. Back. Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Add to watchlist. Stockholm - Stockholm Real-time price. Currency in SEK Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Add to watchlist. Stockholm - Stockholm Real-time price. Currency in SEK. 176.90 +0.20 (+0.11%) As of.

Swedish Orphan Biovitrum Stock price prediction 2021 - (DE

On September 30, Dova Pharmaceuticals said Swedish Orphan Biovitrum will purchase the company for $27.50 a share in cash. If, however, the FDA approves Dova's primary candidate Doptelet, which is used in the treatment of chemotherapy-induced thrombocytopenia, Orphan Biovitrum (OM: SOBI) will buy the company for an additional $1.50 a share Swedish Orphan Biovitrum (Sobi) is a Swedish biopharmaceutical company that is focused on treating rare diseases. The company operates two main business areas, Haemophilia and Specialty Care, and delivers treatments to patients in over 60 countries across the world. The stock is listed on the Stockholm Stock Exchange and currently has a. Køb Swedish Orphan Biovitrum AB (SOBI) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realti Zu Swedish Orphan Biovitrum GmbH in 1. Bezirk / Innere Stadt finden Sie Telefonnummer Adresse sowie Firmeninfos wie UID-Nummer, Firmenbuchnummer, Import-Quote, Geschäftsführer, Gesellschafter ‒ eingetragen unter Medikamente und Arzneimittel / Großhandel in Wie

Swedish Orphan Biovitrum AB (publ) 2019 Q2 - Results

Video: Swedish Orphan Biovitrum AB (publ) Stock Forecast, Price

Swedish Orphan Biovitrum AB (publ) 2020 Q1 - Results

Stockholm, Sweden and Watertown, Mass June 11, 2020-- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Selecta Biosciences, Inc. (Nasdaq: SELB) today announced that the companies have entered into a strategic licensing agreement for the product candidate SEL-212. SEL-212 is a combination of Selecta's tolerogenic ImmTOR immune. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates. Swedish Orphan Biovitrum AB Dividend policy None Price as of: AUG 05, 06:42 AM EDT $19.28 -0.02 -0.1% BIOVF: OTC (Stock) Swedish Orphan Biovitrum AB. Swedish Orphan Biovitrum AB is a biopharmaceutical company, which engages in the provision of specialist pharmaceuticals for rare diseases. It operates through the Product Sales segment which includes proprietary products and products sold through distribution and licensing agreements Swedish Orphan Biovitrum... (PK) (BIOVF) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more

Swedish Orphan Biovitrum (Sobi) är ett Stockholmsbaserat svenskt internationellt specialhälsovårdsföretag inom läkemedelsbranschen som anses vara en pionjär inom bioteknik. Företaget har ett brett sortiment av produkter som används för behandling av genetiska sjukdomar, inom hemofili, neonatologi, onkologi och infektionssjukdomar Despite being rare, a stock may have a negative beta, which means the stock moves opposite the general market trend. Swedish Orphan Biovitrum AB shows a Beta of 0.39. This is significantly lower than 1. The volatility of Swedish Orphan Biovitrum AB according to this measure is significantly lower than the market volatility Swedish Orphan Biovitrum engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals. It offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders Sweden. Swedish Orphan Biovitrum. Swedish Orphan Biovitrum is an international biopharmaceutical company founded in 2010 with over 1500 employees. It is dedicated to treatments in the areas of hematology, immunology, and specialty care THIS STOCK PURCHASE AGREEMENT (this Agreement), dated as of June 11, 2020, is entered into by and between Selecta Biosciences, Inc., a Delaware corporation (the Company), and Swedish Orphan Biovitrum AB (publ), a Swedish public limited liability company (the Purchaser)

(1) Restriction of liability. Content of this website: The content of this website has been prepared with the greatest possible care. However, LANG & SCHWARZ Tradecenter AG & Co. KG assumes no warranty for the accuracy, completeness or currentness of the content provided, particularly for price, market, exchange or other financial information Swedish Orphan Biovitrum is registered under the ticker STO:SOBI . Swedish Orphan Biovitrum has acquired 3 organizations. Their most recent acquisition was Dova Pharmaceuticals on Sep 30, 2019. They acquired Dova Pharmaceuticals for $915M Earnings for Swedish Orphan Biovitrum (SOBI.ST) Earnings in 2021 (TTM): $0.46 B According to Swedish Orphan Biovitrum's latest financial reports the company's current earnings (TTM) are $0.46 B.In 2020 the company made an earning of $0.54 B an increase over its 2019 earnings that were of $0.53 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT

In depth view into Swedish Orphan Biovitrum Market Cap including historical data from 2012, charts, stats and industry comps Swedish Orphan Biovitrum AB est spécialisé dans le développement, la fabrication et la commercialisation de produits thérapeutiques destinés au traitement des maladies rares (hémophilie. 20 May 2021 Full adverse events and efficacy data from a phase III SAVE-MORE trial in COVID-2019 infections released by Swedish Orphan Biovitrum 15 Apr 2021 Hellenic Institute for the Study of Sepsis initiates enrolment in a phase II SAVE trial for COVID-2019 infections in Greece (NCT04357366) (EudraCT2020-001466-11

Team | Aescap 2

Potential Swedish Orphan Biovitrum AB (publ) shareholders may wish to note that insider Milan Zdravkovic recently bought kr3.0m worth of stock, paying kr213 for each share.We reckon that's a good sign, especially since the purchase boosted their holding by 157%. View our latest analysis for Swedish Orphan Biovitrum Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced a definitive agreement to acquire Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) by means of a tender offer. The consideration consists of an upfront payment of USD 27.50 per share in cash and, one non-tradeable Contingent Value Right (CVR) Find company research, competitor information, contact details & financial data for Swedish Orphan Biovitrum AB (Publ) of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet Sweden's Orphan Biovitrum AB (publ) provides full-year 2021 earnings guidance. Revenues for the full year 2021 are expected to range from SEK 14,000 to SEK 15,000. S & P Capital IQ 2021 All news about SWEDISH ORPHAN BIOVITRUM AB (PUBL) Sales 2021 14 714 M 1 693 M 1 693 M Net profit 2021 2 Over the last twelve months Swedish Orphan Biovitrum has recorded a ROE of 16%. Another way to think of that is that for every SEK1 worth of equity in the company, it was able to earn SEK0.16

Dova Announces DOPTELET® (avatrombopag) Data PresentationsBiogen's Little Swedish Orphan Named Sobi - Swedish OrphanÜber BSN medical

Swedish Orphan Biovitrum nimmt um 14% auf 215 SEK die Stockholmer Börse nach starken Ergebnisse für das zweite Quartal 2019 veröffentlichen, darunter ein organisches Umsatzwachstum von 25% und. Swedish Orphan Biovitrum AB (ISIN: SE0000872095, WKN: A0LA5K): Kurs der Swedish Orphan Biovitrum AB Aktie Dividenden-Rendite und Termine, aktuelle Nachrichten Aktien-Sparpla Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB (Sobi) Consideration of up to $29.00 per share includes $27.50 per share in upfront cash and an additional $1.50 per share upon. Swedish Orphan Biovitrum公司简介,包括Swedish Orphan Biovitrum(SOBIs)公司业务概况,联系方式,官网和高管档案资料 Swedish Orphan Biovitrum s.r.o., diskuse, názory, komentáře, hodnocení, fórum a příspěvky k firmě Swedish Orphan Biovitrum s.r.o.